Desferrioxamine mesylate encapsulated novel chitosan based polymeric nanocomposites: insights into drug interaction, biocompatibility, cytotoxicity, cell permeability, antioxidant and controlled release properties (2025)
- Authors:
- Autor USP: ESPOSITO, BRENO PANNIA - IQ
- Unidade: IQ
- DOI: 10.1039/d5ra04417k
- Subjects: NANOCOMPOSITOS; ANTIOXIDANTES
- Agências de fomento:
- Language: Inglês
- Source:
- Título: RSC Advances
- ISSN: 2046-2069
- Volume/Número/Paginação/Ano: v. 15, n. 48, p. 40311-40327, 2025
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
WIMALASIRI, A. K. D. V. K et al. Desferrioxamine mesylate encapsulated novel chitosan based polymeric nanocomposites: insights into drug interaction, biocompatibility, cytotoxicity, cell permeability, antioxidant and controlled release properties. RSC Advances, v. 15, n. 48, p. 40311-40327, 2025Tradução . . Disponível em: https://dx.doi.org/10.1039/d5ra04417k. Acesso em: 22 jan. 2026. -
APA
Wimalasiri, A. K. D. V. K., Kalansuriya, P., Espósito, B. P., Pereira, T. A., Zhao, Y., Godevithana, J. C., et al. (2025). Desferrioxamine mesylate encapsulated novel chitosan based polymeric nanocomposites: insights into drug interaction, biocompatibility, cytotoxicity, cell permeability, antioxidant and controlled release properties. RSC Advances, 15( 48), 40311-40327. doi:10.1039/d5ra04417k -
NLM
Wimalasiri AKDVK, Kalansuriya P, Espósito BP, Pereira TA, Zhao Y, Godevithana JC, Siriwardana K, Mohotti M, Lacerda E. Desferrioxamine mesylate encapsulated novel chitosan based polymeric nanocomposites: insights into drug interaction, biocompatibility, cytotoxicity, cell permeability, antioxidant and controlled release properties [Internet]. RSC Advances. 2025 ; 15( 48): 40311-40327.[citado 2026 jan. 22 ] Available from: https://dx.doi.org/10.1039/d5ra04417k -
Vancouver
Wimalasiri AKDVK, Kalansuriya P, Espósito BP, Pereira TA, Zhao Y, Godevithana JC, Siriwardana K, Mohotti M, Lacerda E. Desferrioxamine mesylate encapsulated novel chitosan based polymeric nanocomposites: insights into drug interaction, biocompatibility, cytotoxicity, cell permeability, antioxidant and controlled release properties [Internet]. RSC Advances. 2025 ; 15( 48): 40311-40327.[citado 2026 jan. 22 ] Available from: https://dx.doi.org/10.1039/d5ra04417k - Complexos metálicos para o tratamento de leishmaniose baseados em inibidores específicos da tripanotiona redutase
- Impact of conditioning and engraftment on iron status in hematopoietic stem cell transplantation: contribution of labile plasma iron [Editorial]
- Antioxidant activity and cellular uptake of the hydroxamate-based fungal iron chelators pyridoxatin, desferriastechrome and desferricoprogen
- Estudo dos produtos de reação entre carboxilatos de rodio (II) e amidas
- New PKS-NRPS tetramic acids and pyridinone from an Australian marine-derived fungus, Chaunopycnis sp.
- Impact of labile plasma iron and iron chelation on the viability of cultured mononuclear cells from patients undergoing autologous hematopoietic stem cell transplantation [Editorial]
- Danos bioquímicos e neuronais promovidos por diferentes espécies de 'MN'(III)
- Um novo complexo diflunisal ferroso e seus efeitos sobre as bioreservas de ferro lábil
- Magnetic Resonance Imaging (MRI) detection of iron overload in patients with Myelodysplastic Syndrome (MDS)
- Ferro: um metal que vale ouro
Informações sobre o DOI: 10.1039/d5ra04417k (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
